April 24, 2018 / 8:02 AM / a month ago

BRIEF-Rovi Signs Agreement With Hikma To Distribute Its Enoxaparin Biosimilar

April 24 (Reuters) - Laboratorios Farmaceuticos Rovi SA :

* SAYS SIGNS AGREEMENT WITH HIKMA TO DISTRIBUTE AND MARKET ITS ENOXAPARIN BIOSIMILAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below